251 related articles for article (PubMed ID: 20089542)
1. In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent.
Seifert K; Escobar P; Croft SL
J Antimicrob Chemother; 2010 Mar; 65(3):508-11. PubMed ID: 20089542
[TBL] [Abstract][Full Text] [Related]
2. In vitro interactions between sitamaquine and amphotericin B, sodium stibogluconate, miltefosine, paromomycin and pentamidine against Leishmania donovani.
Seifert K; Munday J; Syeda T; Croft SL
J Antimicrob Chemother; 2011 Apr; 66(4):850-4. PubMed ID: 21393188
[TBL] [Abstract][Full Text] [Related]
3. Combination of paromomycin and miltefosine promotes TLR4-dependent induction of antileishmanial immune response in vitro.
Das S; Rani M; Pandey K; Sahoo GC; Rabidas VN; Singh D; Das P
J Antimicrob Chemother; 2012 Oct; 67(10):2373-8. PubMed ID: 22761329
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 1alpha activity of peritoneal and bone marrow macrophages infected with Leishmania major and Leishmania donovani in vitro.
Bersudsky M; Apte RN; El-On J
Exp Parasitol; 2000 Mar; 94(3):150-7. PubMed ID: 10831379
[TBL] [Abstract][Full Text] [Related]
5. Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.
Escobar P; Yardley V; Croft SL
Antimicrob Agents Chemother; 2001 Jun; 45(6):1872-5. PubMed ID: 11353640
[TBL] [Abstract][Full Text] [Related]
6. Miltefosine promotes IFN-gamma-dominated anti-leishmanial immune response.
Wadhone P; Maiti M; Agarwal R; Kamat V; Martin S; Saha B
J Immunol; 2009 Jun; 182(11):7146-54. PubMed ID: 19454711
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo interactions between miltefosine and other antileishmanial drugs.
Seifert K; Croft SL
Antimicrob Agents Chemother; 2006 Jan; 50(1):73-9. PubMed ID: 16377670
[TBL] [Abstract][Full Text] [Related]
8. Potential of doxorubicin as an antileishmanial agent.
Sett R; Basu N; Ghosh AK; Das PK
J Parasitol; 1992 Apr; 78(2):350-4. PubMed ID: 1556650
[TBL] [Abstract][Full Text] [Related]
9. Targeting Leishmania (L.) chagasi amastigotes through macrophage scavenger receptors: the use of drugs entrapped in liposomes containing phosphatidylserine.
Tempone AG; Perez D; Rath S; Vilarinho AL; Mortara RA; de Andrade HF
J Antimicrob Chemother; 2004 Jul; 54(1):60-8. PubMed ID: 15163652
[TBL] [Abstract][Full Text] [Related]
10. Leishmania donovani: an in vitro study of antimony-resistant amphotericin B-sensitive isolates.
Sharief AH; Gasim Khalil EA; Theander TG; Kharazmi A; Omer SA; Ibrahim ME
Exp Parasitol; 2006 Dec; 114(4):247-52. PubMed ID: 16716301
[TBL] [Abstract][Full Text] [Related]
11. N-(2-hydroxypropyl)methacrylamide-amphotericin B (HPMA-AmB) copolymer conjugates as antileishmanial agents.
Nicoletti S; Seifert K; Gilbert IH
Int J Antimicrob Agents; 2009 May; 33(5):441-8. PubMed ID: 19097763
[TBL] [Abstract][Full Text] [Related]
12. Quassin alters the immunological patterns of murine macrophages through generation of nitric oxide to exert antileishmanial activity.
Bhattacharjee S; Gupta G; Bhattacharya P; Mukherjee A; Mujumdar SB; Pal A; Majumdar S
J Antimicrob Chemother; 2009 Feb; 63(2):317-24. PubMed ID: 19036753
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics and cellular accumulation of amphotericin B and miltefosine in Leishmania donovani-infected primary macrophages.
Voak AA; Standing JF; Sepúlveda N; Harris A; Croft SL; Seifert K
J Antimicrob Chemother; 2018 May; 73(5):1314-1323. PubMed ID: 29506127
[TBL] [Abstract][Full Text] [Related]
14. Activity of antileishmanial agents against amastigotes in human monocyte-derived macrophages and in mouse peritoneal macrophages.
Berman JD; Lee LS
J Parasitol; 1984 Apr; 70(2):220-5. PubMed ID: 6088749
[TBL] [Abstract][Full Text] [Related]
15. Amphotericin B inhibits entry of Leishmania donovani into primary macrophages.
Paila YD; Saha B; Chattopadhyay A
Biochem Biophys Res Commun; 2010 Aug; 399(3):429-33. PubMed ID: 20678487
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of clinical isolates of Leishmania aethiopica to miltefosine, paromomycin, amphotericin B and sodium stibogluconate using amastigote-macrophage in vitro model.
Utaile M; Kassahun A; Abebe T; Hailu A
Exp Parasitol; 2013 May; 134(1):68-75. PubMed ID: 23434530
[TBL] [Abstract][Full Text] [Related]
17. Antileishmanial activity of hydrolyzable tannins and their modulatory effects on nitric oxide and tumour necrosis factor-alpha release in macrophages in vitro.
Kolodziej H; Kayser O; Kiderlen AF; Ito H; Hatano T; Yoshida T; Foo LY
Planta Med; 2001 Dec; 67(9):825-32. PubMed ID: 11745019
[TBL] [Abstract][Full Text] [Related]
18. Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening.
Singh N; Gupta R; Jaiswal AK; Sundar S; Dube A
J Antimicrob Chemother; 2009 Aug; 64(2):370-4. PubMed ID: 19525291
[TBL] [Abstract][Full Text] [Related]
19. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
[TBL] [Abstract][Full Text] [Related]
20. Lymphokine mediated microbicidal activity of peritoneal macrophages from Leishmania donovani infected and drug treated BALB/c mice.
Sodhi S; Ganguly NK; Malla N; Mahajan RC
Jpn J Exp Med; 1989 Jun; 59(3):103-8. PubMed ID: 2554031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
